Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Attends the Canadian Society of Echocardiography Conference in Toronto

TheNewsWire April 23, 2018

Ventripoint to Issue Shares for Service to CEO and Consultants

TheNewsWire March 29, 2018

Ventripoint and Ryerson University Have Been Approved for Government Funding to Advance Artificial Intelligence in Medical Imaging

TheNewsWire March 26, 2018

Ventripoint Appoints Dr. Samuel Schwartz Chair of Business Advisory Committee

TheNewsWire March 14, 2018

Ventripoint Named to 2018 TSX Venture 50 Group of Top Performing Companies

TheNewsWire February 22, 2018

First Ventripoint Whole Heart System Operational at University of Alberta Mazankowski Heart Institute

TheNewsWire February 21, 2018

Ventripoint Adds Hospital Networking Expert to Implementation Team

TheNewsWire February 7, 2018

IIROC Trading Resumption - VPT

Canada NewsWire January 17, 2018

IIROC Trade Resumption - VentriPoint Diagnostics Ltd.

Newsfile January 17, 2018

Ventripoint Applies to US FDA for Market Clearance for the VMS+ Whole-Heart Analysis System

TheNewsWire January 17, 2018

IIROC Trading Halt - VPT

Canada NewsWire January 17, 2018

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile January 17, 2018

Ventripoint Appoints Head of Sales for North America

TheNewsWire January 10, 2018

IIROC Trading Resumption - VPT

Canada NewsWire January 8, 2018

Ventripoint Receives CE Mark for VMS+ Whole Heart Analysis System

TheNewsWire January 8, 2018

IIROC Trading Halt - VPT

Canada NewsWire January 8, 2018

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile January 8, 2018

Ventripoint Applies for CE Mark for VMS+ Device and Complete Heart Analysis System

TheNewsWire December 20, 2017

Ventripoint Provides Corporate Update

TheNewsWire December 19, 2017

Ventripoint Exhibits at Major Heart Imaging Conference in Europe

GlobeNewswire December 6, 2017